Evidence map›Paper›PMID 31745563›Full record

ArticleNucleic acids research2020

Phylogenetic debugging of a complete human biosynthetic pathway transplanted into yeast.

Neta Agmon, Jasmine Temple, Zuojian Tang, Tobias Schraink, Maayan Baron, Jun Chen, Paolo Mita, James A Martin, Benjamin P Tu, Itai Yanai and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Neta AgmonInstitute for Systems Genetics and Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, NY, USA.
Jasmine TempleInstitute for Systems Genetics and Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, NY, USA.
Zuojian TangMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Tobias SchrainkCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, NY, USA.
Maayan BaronInstitute for Computational Medicine and Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, NY, USA.
Jun ChenDepartment of Biochemistry, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Paolo MitaInstitute for Systems Genetics and Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, NY, USA.
James A MartinInstitute for Systems Genetics and Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, NY, USA.
Benjamin P TuDepartment of Biochemistry, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Itai YanaiInstitute for Computational Medicine and Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, NY, USA.
David FenyöInstitute for Systems Genetics and Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, NY, USA.
Jef D BoekeInstitute for Systems Genetics and Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, NY, USA.
Institute for Systems Biology · USThe University of Texas Southwestern Medical Center · USMemorial Sloan Kettering Cancer Center · USNew York University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Lesch-Nyhan Disease: A Model for Complex Genetic, Proteomic & Metabolic PathwaysR24DK082840 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FRIEDMANN, THEODORE · 2008 to 2012
$7.3M
Metabolic signals regulating cell growth versus survivalR35GM136370 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI Benjamin P Tu · 2020 to 2026
$2.8M
NCI NIH HHS P30 CA008748NIDDK NIH HHS R24 DK082840NIGMS NIH HHS R35 GM136370
6 · The paper itself

Abstract

Cross-species pathway transplantation enables insight into a biological process not possible through traditional approaches. We replaced the enzymes catalyzing the entire Saccharomyces cerevisiae adenine de novo biosynthesis pathway with the human pathway. While the 'humanized' yeast grew in the absence of adenine, it did so poorly. Dissection of the phenotype revealed that PPAT, the human ortholog of ADE4, showed only partial function whereas all other genes complemented fully. Suppressor analysis revealed other pathways that play a role in adenine de-novo pathway regulation. Phylogenetic analysis pointed to adaptations of enzyme regulation to endogenous metabolite level 'setpoints' in diverse organisms. Using DNA shuffling, we isolated specific amino acids combinations that stabilize the human protein in yeast. Thus, using adenine de novo biosynthesis as a proof of concept, we suggest that the engineering methods used in this study as well as the debugging strategies can be utilized to transplant metabolic pathway from any origin into yeast.

Indexed as

AdenineAmino Acid SequenceBiosynthetic PathwaysCarboxy-LyasesChromosomes, Artificial, HumanCRISPR-Cas SystemsGenetic Complementation TestGenetic EngineeringHumansIsoenzymesPeptide SynthasesPhylogenyPlasmidsSaccharomyces cerevisiaeSequence AlignmentSequence Homology, Amino AcidAdenineCarboxy-LyasesIsoenzymesPeptide Synthases

Identifiers

PMID31745563
PMCPMC7145547
OpenAlexW2997114067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.